Proposals for influenza vaccine
PHARMAC is seeking feedback on a proposal to list two brands of influenza vaccine in the Pharmaceutical Schedule for the 2014, 2015, and 2016 influenza seasons.
In summary, this proposal would result in:
- Influvac, Influvac Junior and Fluarix being listed in Section H and Section I of the Pharmaceutical Schedule from 1 January 2014 under the eligibility criteria set by PHARMAC.
- 250,000 doses of Fluarix would be distributed each season in preference to Influvac and Influvac Junior, after which supplies of Influvac and Influvac Junior would be expected to meet the remaining demand of the market.
PHARMAC welcomes feedback on this proposal. To provide feedback, please submit it in writing by 4 pm, Tuesday, 3 September 2013 to:
Senior Therapeutic Group Manager
PO Box 10 254
Fax: 04 460 4995
All feedback received before the closing date will be considered by PHARMAC’s Board (or its delegate) prior to making a decision on this proposal.